EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update

EUDA Health Holdings Limited (NASDAQ:EUDAGet Free Report) was the target of a large decrease in short interest in the month of July. As of July 31st, there was short interest totaling 2,417 shares, a decrease of 52.4% from the July 15th total of 5,079 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 5,465 shares, the short-interest ratio is presently 0.4 days.

Institutional Trading of EUDA Health

A hedge fund recently raised its stake in EUDA Health stock. Citadel Advisors LLC lifted its position in EUDA Health Holdings Limited (NASDAQ:EUDAFree Report) by 57.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 44,631 shares of the company’s stock after purchasing an additional 16,321 shares during the quarter. Citadel Advisors LLC owned 0.12% of EUDA Health worth $78,000 at the end of the most recent reporting period. 4.35% of the stock is owned by hedge funds and other institutional investors.

EUDA Health Stock Up 2.3%

NASDAQ EUDA traded up $0.32 during trading on Friday, reaching $14.32. 836 shares of the company traded hands, compared to its average volume of 5,688. EUDA Health has a 1-year low of $5.26 and a 1-year high of $86.00. The stock’s 50 day moving average price is $14.93 and its two-hundred day moving average price is $14.63.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on EUDA shares. Zacks Research upgraded shares of EUDA Health from a “strong sell” rating to a “hold” rating in a research note on Friday, May 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of EUDA Health in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, EUDA Health presently has an average rating of “Hold” and a consensus target price of $55.00.

View Our Latest Stock Report on EUDA Health

About EUDA Health

(Get Free Report)

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.

Featured Stories

Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.